Cyr61 Expression Pattern and Association with Clinico-pathological Factors in Patients with Cervical Cancer

Sebastian Mayer*, Boris Gabriel, Thalia Erbes, Sylvia Timme-Bronsert, Markus Jaeger, Gerta Ruecker, Franciska Kuf, Jiri Bouda, Alena Bartakova, Axel Zur Hausen, Elmar Stickeler, Gerald Gitsch, Marc Hirschfeld

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2451-2456
Number of pages6
JournalAnticancer Research
Volume37
Issue number5
DOIs
Publication statusPublished - May 2017

Keywords

  • Cyr61
  • cervical cancer
  • hTra2 beta
  • overall survival
  • histologic grade
  • IMMEDIATE-EARLY GENE
  • ENDOMETRIAL CANCER
  • GROWTH
  • PROGNOSIS
  • METAANALYSIS
  • METASTASIS
  • CARCINOMA
  • FAMILY
  • CELLS
  • IL-6

Cite this

Mayer, S., Gabriel, B., Erbes, T., Timme-Bronsert, S., Jaeger, M., Ruecker, G., Kuf, F., Bouda, J., Bartakova, A., Zur Hausen, A., Stickeler, E., Gitsch, G., & Hirschfeld, M. (2017). Cyr61 Expression Pattern and Association with Clinico-pathological Factors in Patients with Cervical Cancer. Anticancer Research, 37(5), 2451-2456. https://doi.org/10.21873/anticanres.11585